Dr. Guillermo Moreno-Sanz has been dedicated to cannabinoid research for almost 20 years and is the author of more than 30 scientific articles and 3 patents describing the role of the endocannabinoid system in pain perception. He holds a degree in Biochemistry and Organic Chemistry from the University of Zaragoza and a PhD in Neuroscience from the Complutense University of Madrid. He obtained a Fulbright scholarship to complete his PhD in the United States, developing most of his academic career at the University of California, Irvine. In 2017, he participated in the elaboration of the report „The Health Effects of Cannabis and Cannabinoids“ of the National Academies of Sciences of the United States.  He currently serves as Chief Scientific Officer of Khiron Life Sciences, a provider of cannabis-based medicines and healthcare services through its network of Zerenia™ clinics, with a presence in Colombia, Peru, Brazil, Spain, the UK and Germany.